Literature DB >> 34720095

NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.

Wan-Chen Hsieh1,2, En-Yu Lai3, Yu-Ting Liu4, Yi-Fu Wang1, Yi-Shiuan Tzeng1, Lu Cui5, Yun-Ju Lai1,6, Hsiang-Chi Huang1, Jia-Hsin Huang4,7, Hung-Chih Ni4, Dong-Yan Tsai8, Jian-Jong Liang1, Chun-Che Liao1, Ya-Ting Lu1, Laurence Jiang1, Ming-Tsan Liu9, Jann-Tay Wang10, Sui-Yuan Chang11,12, Chung-Yu Chen13, Hsing-Chen Tsai10,13, Yao-Ming Chang1, Gerlinde Wernig5, Chia-Wei Li1, Kuo-I Lin8, Yi-Ling Lin1,14, Huai-Kuang Tsai4, Yen-Tsung Huang2,3,15, Shih-Yu Chen1,2.   

Abstract

To explore how the immune system controls clearance of SARS-CoV-2, we used a single-cell, mass cytometry-based proteomics platform to profile the immune systems of 21 patients who had recovered from SARS-CoV-2 infection without need for admission to an intensive care unit or for mechanical ventilation. We focused on receptors involved in interactions between immune cells and virus-infected cells. We found that the diversity of receptor repertoires on natural killer (NK) cells was negatively correlated with the viral clearance rate. In addition, NK subsets expressing the receptor DNAM1 were increased in patients who more rapidly recovered from infection. Ex vivo functional studies revealed that NK subpopulations with high DNAM1 expression had cytolytic activities in response to target cell stimulation. We also found that SARS-CoV-2 infection induced the expression of CD155 and nectin-4, ligands of DNAM1 and its paired coinhibitory receptor TIGIT, which counterbalanced the cytolytic activities of NK cells. Collectively, our results link the cytolytic immune responses of NK cells to the clearance of SARS-CoV-2 and show that the DNAM1 pathway modulates host-pathogen interactions during SARS-CoV-2 infection.

Entities:  

Keywords:  COVID-19; NK cells

Mesh:

Substances:

Year:  2021        PMID: 34720095      PMCID: PMC8553551          DOI: 10.1172/JCI146408

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

2.  The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.

Authors:  Hamid Bolouri; Cate Speake; David Skibinski; S Alice Long; Anne M Hocking; Daniel J Campbell; Jessica A Hamerman; Uma Malhotra; Jane H Buckner
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

3.  Platinum-conjugated antibodies for application in mass cytometry.

Authors:  Henrik E Mei; Michael D Leipold; Holden T Maecker
Journal:  Cytometry A       Date:  2015-09-10       Impact factor: 4.355

4.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.

Authors:  Chaomin Wu; Xiaoyan Chen; Yanping Cai; Jia'an Xia; Xing Zhou; Sha Xu; Hanping Huang; Li Zhang; Xia Zhou; Chunling Du; Yuye Zhang; Juan Song; Sijiao Wang; Yencheng Chao; Zeyong Yang; Jie Xu; Xin Zhou; Dechang Chen; Weining Xiong; Lei Xu; Feng Zhou; Jinjun Jiang; Chunxue Bai; Junhua Zheng; Yuanlin Song
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

5.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.

Authors:  Evangelos J Giamarellos-Bourboulis; Mihai G Netea; Nikoletta Rovina; Karolina Akinosoglou; Anastasia Antoniadou; Nikolaos Antonakos; Georgia Damoraki; Theologia Gkavogianni; Maria-Evangelia Adami; Paraskevi Katsaounou; Maria Ntaganou; Magdalini Kyriakopoulou; George Dimopoulos; Ioannis Koutsodimitropoulos; Dimitrios Velissaris; Panagiotis Koufargyris; Athanassios Karageorgos; Konstantina Katrini; Vasileios Lekakis; Mihaela Lupse; Antigone Kotsaki; George Renieris; Danai Theodoulou; Vassiliki Panou; Evangelia Koukaki; Nikolaos Koulouris; Charalambos Gogos; Antonia Koutsoukou
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

6.  Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.

Authors:  Pierre Bost; Amir Giladi; Yang Liu; Yanis Bendjelal; Gang Xu; Eyal David; Ronnie Blecher-Gonen; Merav Cohen; Chiara Medaglia; Hanjie Li; Aleksandra Deczkowska; Shuye Zhang; Benno Schwikowski; Zheng Zhang; Ido Amit
Journal:  Cell       Date:  2020-05-08       Impact factor: 41.582

7.  Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity.

Authors:  Lu Cui; Shih-Yu Chen; Tristan Lerbs; Jin-Wook Lee; Pablo Domizi; Sydney Gordon; Yong-Hun Kim; Garry Nolan; Paola Betancur; Gerlinde Wernig
Journal:  Nat Commun       Date:  2020-06-03       Impact factor: 14.919

8.  Comprehensive mapping of immune perturbations associated with severe COVID-19.

Authors:  Leticia Kuri-Cervantes; M Betina Pampena; Wenzhao Meng; Aaron M Rosenfeld; Caroline A G Ittner; Ariel R Weisman; Roseline S Agyekum; Divij Mathew; Amy E Baxter; Laura A Vella; Oliva Kuthuru; Sokratis A Apostolidis; Luanne Bershaw; Jeanette Dougherty; Allison R Greenplate; Ajinkya Pattekar; Justin Kim; Nicholas Han; Sigrid Gouma; Madison E Weirick; Claudia P Arevalo; Marcus J Bolton; Eileen C Goodwin; Elizabeth M Anderson; Scott E Hensley; Tiffanie K Jones; Nilam S Mangalmurti; Eline T Luning Prak; E John Wherry; Nuala J Meyer; Michael R Betts
Journal:  Sci Immunol       Date:  2020-07-15

9.  PD-L1 Dysregulation in COVID-19 Patients.

Authors:  Francesco Sabbatino; Valeria Conti; Gianluigi Franci; Carmine Sellitto; Valentina Manzo; Pasquale Pagliano; Emanuela De Bellis; Alfonso Masullo; Francesco Antonio Salzano; Alessandro Caputo; Ilaria Peluso; Pio Zeppa; Giosuè Scognamiglio; Giuseppe Greco; Carla Zannella; Michele Ciccarelli; Claudia Cicala; Carmine Vecchione; Amelia Filippelli; Stefano Pepe
Journal:  Front Immunol       Date:  2021-06-07       Impact factor: 7.561

View more
  11 in total

Review 1.  Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.

Authors:  Clara Di Vito; Francesca Calcaterra; Nicolò Coianiz; Sara Terzoli; Antonio Voza; Joanna Mikulak; Silvia Della Bella; Domenico Mavilio
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 2.  Exploring the Utility of NK Cells in COVID-19.

Authors:  Xuewen Deng; Hiroshi Terunuma; Mie Nieda
Journal:  Biomedicines       Date:  2022-04-26

3.  Concerns over functional experiments, interpretation, and required controls.

Authors:  Eddie Cy Wang; Ceri A Fielding; Richard J Stanton
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

4.  Concerns over functional experiments, interpretation, and required controls. Reply.

Authors:  Wan-Chen Hsieh; Shih-Yu Chen
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

5.  CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.

Authors:  Martha Sedegah; Chad Porter; Michael R Hollingdale; Harini Ganeshan; Jun Huang; Carl W Goforth; Maria Belmonte; Arnel Belmonte; Dawn L Weir; Rhonda A Lizewski; Stephen E Lizewski; Stuart C Sealfon; Vihasi Jani; Ying Cheng; Sandra Inoue; Rachael Velasco; Eileen Villasante; Peifang Sun; Andrew G Letizia
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

Review 6.  CyTOF® for the Masses.

Authors:  Akshay Iyer; Anouk A J Hamers; Asha B Pillai
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

Review 7.  Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients.

Authors:  Mohammad A Al-Mterin; Alhasan Alsalman; Eyad Elkord
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

8.  DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study.

Authors:  Chiara Focaccetti; Monica Benvenuto; Chiara Pighi; Alessandra Vitelli; Federico Napolitano; Nicola Cotugno; Doriana Fruci; Paolo Palma; Paolo Rossi; Roberto Bei; Loredana Cifaldi
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 9.  SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations.

Authors:  Patrida Rangchaikul; Vishwanath Venketaraman
Journal:  Infect Dis Rep       Date:  2021-11-30

10.  Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients.

Authors:  José L Casado; Elisa Moraga; Pilar Vizcarra; Héctor Velasco; Adrián Martín-Hondarza; Johannes Haemmerle; Sandra Gómez; Carmen Quereda; Alejandro Vallejo
Journal:  Viruses       Date:  2021-12-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.